Keyphrases
Biologic Pathways
6%
Chest CT
6%
Chronic Obstructive Pulmonary Disease
20%
Control Subjects
6%
COPDGene
6%
DPP9
6%
FAM13A
6%
Framingham
6%
Gene-environment
6%
Genetic Epidemiology
6%
Genetic Risk
100%
Genetic Risk Loci
6%
Genome-wide Association
6%
Genome-wide Association Study
20%
Genome-wide Genotyping
6%
High Genetic Risk
6%
Idiopathic Pulmonary Fibrosis
100%
Interstitial Lung Abnormalities
100%
IPO11
6%
Meta-analysis
6%
MUC5B
20%
Multi-Ethnic Study of Atherosclerosis
6%
Non-associated
13%
Predominant Subtype
6%
Promoter Variants
13%
Rs35705950
6%
Subpleural
20%
Surrogate Endpoint
6%
Medicine and Dentistry
Atherosclerosis
12%
Biological Product
12%
Chronic Obstructive Pulmonary Disease
37%
Computer Assisted Tomography
12%
Genetic Epidemiology
12%
Genetic Risk
100%
Genome Wide Association Study
50%
Genotype
12%
Idiopathic Pulmonary Fibrosis
100%
Meta-Analysis
12%
Mucin 5B
37%
Promoter Region
25%
Pharmacology, Toxicology and Pharmaceutical Science
Atherosclerosis
12%
Biological Product
12%
Chronic Obstructive Lung Disease
37%
Fibrosing Alveolitis
100%
Genetic Epidemiology
12%
Genetic Risk
100%
Mucin 5B
37%